Alessia Di Sapio graduated in Medicine and Surgery in 1991 at the School Medicine of University of Turin, where she specialized in Neurology in 1995.
As a medical student her field of research was experimental neurophysiology on animal models, with Prof. Strata, which she continued for a short internship at Brown University, where she took part in brain mapping experiments with Prof John Donoghue. During her fellowship in Neurology she conducted research in the field of cerebral tumor in adult and pediatrics, studying the role of growth factors in cell culture and genetic abnormalities in gliomas by molecular biology techniques.
Besides she performed genetic tests for a hATTR-FAP, an inherited neuropathy.
At the MS Regional Referral center she lead research activity in the field of experimental clinical neurophysiology applied to multiple sclerosis (MS). Besides she was involved as principal or co-investigator in several phase III and IV clinical studies on MS therapies.
Research focus
Dr. Di Sapio is involved in research in the field of demyelinating diseases, with the aim to ameliorate MS patients’ follow up, studying increasingly reliable fluid biomarkers of disease activity and progression applicable in clinical practice. In clinical research she is oriented to consolidate a multidimensional approach to patient care that takes into consideration both physical and psychological aspects: research activities of her groups are oriented to pursue the goal of personalized medicine.
As Director of the first Italian BioBank centered on MS, Dr. Di Sapio promotes and consolidates the Biobank’s activity, important infrastructure for researchers in Italy and abroad.
Dr. Di Sapio’s skills include execution and reporting of neurophysiological tests (EEG, EMG, multimodal evoked potentials) and non invasive neuromodulation techniques. She is the author or co-author of 69 papers.
